News about PFE

U.S. stocks keep hitting record highs, but the so-called Warren Buffett indicator, the total market cap of U.S. stocks relative to GDP, stands at a record 237.5%, far above the 138.5% peak during the early-2000 dot-com mania. The author argues the backdrop shapes how to invest rather than whether to invest, and recommends Pfizer (PFE) and Alphabet (GOOG, GOOGL) despite the warning. Pfizer's revenue has fallen from just over $100 billion in 2021 to around $60 billion, and patent expirations threaten roughly one-third of its drug portfolio, but Padcev sales reached $667 million in Q2, up 23%, and its forward dividend yield is nearly 6%. Alphabet is well positioned in AI as its Gemini chatbot outgrows competitors, Google handles nearly 90% of the world's web queries, and Android runs on 69% of the world's mobile devices.

The article profiles five high-yield dividend stocks: Altria (MO), AGNC Investment (AGNC), Energy Transfer (ET), Pfizer (PFE), and Realty Income (O), with trailing 12-month yields as of Oct. 14 of 5.93%, 16.72%, 6.57%, 6.06%, and 5.88%, respectively. Altria is a Dividend King with 57 years of rising payouts, while AGNC, a mortgage REIT, may see its dividend at risk in a rising rate environment. Energy Transfer has raised its dividend for 19 consecutive quarters and shows strong distributable cash flow growth, and Pfizer paid $9.8 billion in cash dividends in 2025. Realty Income reports 98.8% occupancy as of June 30 and has raised its dividend for 116 straight quarters. The article notes that dividends are not guaranteed and yields can fall as share prices rise.